We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNT icon
1626
Cognyte Software
CGNT
$636M
-44,699
Closed -$362K
CHCO icon
1627
City Holding Co
CHCO
$2.03B
-8,452
Closed -$1.01M
CHE icon
1628
Chemed
CHE
$7.07B
-35,775
Closed -$13.5M
CI icon
1629
Cigna
CI
$73.3B
-44,615
Closed -$11.9M
CIGI icon
1630
Colliers International
CIGI
$5.47B
-25,700
Closed -$2.75M
CLF icon
1631
Cleveland-Cliffs
CLF
$6.43B
-664,054
Closed -$5.61M
CLS icon
1632
Celestica
CLS
$37.4B
-19,660
Closed -$5.54M
CLVT icon
1633
Clarivate
CLVT
$1.33B
-626,596
Closed -$1.59M
CMI icon
1634
Cummins
CMI
$80.9B
-24,493
Closed -$13.2M
CMRE icon
1635
Costamare
CMRE
$1.89B
-126,526
Closed -$2.14M
CNNE icon
1636
Cannae Holdings
CNNE
$672M
-204,258
Closed -$2.32M
COCO icon
1637
Vita Coco
COCO
$3.67B
-37,593
Closed -$1.8M
COGT icon
1638
Cogent Biosciences
COGT
$6.37B
-372,175
Closed -$14.3M
COO icon
1639
Cooper Companies
COO
$14.9B
-573,202
Closed -$41M
CORT icon
1640
Corcept Therapeutics
CORT
$13.2B
-106,147
Closed -$4.28M
CORZ icon
1641
Core Scientific
CORZ
$5.72B
-57,484
Closed -$860K
COUR icon
1642
Coursera
COUR
$1.59B
-57,871
Closed -$337K
CPF icon
1643
Central Pacific Financial
CPF
$964M
-11,649
Closed -$372K
CPK icon
1644
Chesapeake Utilities
CPK
$3.23B
-2,020
Closed -$255K
CPS icon
1645
Cooper-Standard Automotive
CPS
$498M
-27,693
Closed -$772K
CRL icon
1646
Charles River Laboratories
CRL
$14.1B
-14,469
Closed -$2.5M
CRNC icon
1647
Cerence
CRNC
$365M
-15,060
Closed -$95K
CRUS icon
1648
Cirrus Logic
CRUS
$5.78B
-9,476
Closed -$1.37M
CSTL icon
1649
Castle Biosciences
CSTL
$1.04B
-32,608
Closed -$801K
CTLP
1650
DELISTED
Cantaloupe
CTLP
-12,859
Closed -$139K

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.